A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~27 mi. (Georgsmarienhütte, Germany, +172 more cities)

Franziskus-Hospital Harderberg

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~27 mi. (Georgsmarienhütte, Germany, +94 more cities)

MVZ II der Niels Stensen Kliniken

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~27 mi. (Georgsmarienhütte, Germany, +184 more cities)

Franziskus-Hospital Harderberg

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~44 mi. (Münster, Germany, +226 more cities)

Universitaetsklinikum Muenster ( Site 0320)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

~44 mi. (Münster, Germany, +122 more cities)

Universitätsklinikum Münster (UKM)

Prostate Adenocarcinoma

radium Ra 223 dichloride

radiation therapy

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~44 mi. (Münster, Germany, +93 more cities)

Universitaetsklinikum Muenster ( Site 0516)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~44 mi. (Münster, Germany, +158 more cities)

GEHO Muenster ( Site 0910)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~44 mi. (Münster, Germany, +126 more cities)

Universitaetsklinikum Muenster ( Site 0248)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~44 mi. (Münster, Germany, +127 more cities)

Universitaetsklinikum Muenster /ID# 215213

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

~44 mi. (Münster, Germany, +180 more cities)

Exelixis Clinical Site #179

Prostate Adenocarcinoma

atezolizumab, +1 more drug

immunotherapy, +1 more type

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

~44 mi. (Münster, Germany, +75 more cities)

Universitätsklinikum Münster - Albert Schweitzer Campus-Pädiatrische Hämatologie und Onkologie ( Sit

Classical Hodgkin Lymphoma

bleomycin, +9 more drugs

chemotherapy, +2 more types

A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma

~44 mi. (Münster, Germany, +6 more cities)

Universitaetsklinikum Muenster /ID# 239637

Multiple Myeloma

TNB-383B

immunotherapy